# An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors

> **NCT01466569** · PHASE1 · COMPLETED · sponsor: **AbGenomics B.V Taiwan Branch** · enrollment: 13 (actual)

## Conditions studied

- Solid Tumor of Epithelial Origin
- Gastric Cancer

## Interventions

- **DRUG:** AbGn-7
- **DRUG:** AbGn-7

## Key facts

- **NCT ID:** NCT01466569
- **Lead sponsor:** AbGenomics B.V Taiwan Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466569, "An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01466569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*